Adv Pharmacol 93:3576
doi: 10.1136/jitc-2024-SITC2024.0740 150 DuWHuangYChenXDengYSunYYangHet al
Combining retatrutide with anabolic substances or performance-enhancing drugs as sometimes discussed in online forums is not clinically sanctioned and may carry serious cardiovascular and endocrine risks
In addition, the characterized LASSS treatment did not stimulate autolysis of HGF as monitored by SDS-PAGE for degradation of 60-kDa -chain and 90-kDa proform of recombinant HGF incubated with LASSS (at 1:8000) at 25 for 2 h (see supplementary Figure 1b), providing another important basis for the availability of LASSS-HGF
The community uses a few names for this combo: reta/cag , reta-cag blend , the LEAN blend , the 4-receptor stack , or supplier brand names like ma-3rt / cag and fg3-r / cag
38.McLelland, G.-L., Goiran, T., Yi, W., Dorval, G., Chen, C